NKTR - NEKTAR THERAPEUTICS
70.7
-1.750 -2.475%
Share volume: 734,773
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$72.45
-1.75
-0.02%
Summary score
52%
Profitability
0%
Dept financing
50%
Liquidity
68%
Performance
100%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-364.55%
Return on assets
-4.28%
Return on sales
-96.79%
Return on invested capital
-42.55%
Total debt ratio
95.37%
Debt ratio change over timeo
0%
Current Ratio
4.51%
Quick Ratio
4.36%
Cash Position Ratio
0.52%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-471.62%
Return on assets
-3.42%
Return on sales
-98.35%
Return on invested capital
-36.88%
Total debt ratio
90.22%
Debt ratio change over timeo
0%
Current Ratio
4.71%
Quick Ratio
4.56%
Cash Position Ratio
0.44%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
72.33%
Return on assets
11.94%
Return on sales
45.44%
Return on invested capital
57.04%
Total debt ratio
85.54%
Debt ratio change over time
0%
Current Ratio
4.14%
Quick Ratio
3.99%
Cash Position Ratio
0.41%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NKTR | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -364.55% | 4.12% | 5.6% | 28.84% |
| Return on assets | -4.28% | 2.87% | 3.58% | 3.88% |
| Return on sales | -96.79% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | -42.55% | 4.34% | 6.5% | 4.27% |
| Profitability | 0% | 52% | 72% | 91% |
| Total debt ratio | 95.37% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 17% | 13% | 24% |
| Current Ratio | 4.71% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 4.56% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.44% | 0.31% | 0.62% | 0.55% |
| Liquididy | 70% | 26% | 47% | 41% |
| Short-term ratios | NKTR | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -471.62% | 3.9% | 5.53% | 29.97% |
| Return on assets | -3.42% | 2.93% | 3.51% | 3.83% |
| Return on sales | -98.35% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | -36.88% | 4.21% | 6.14% | 4.25% |
| Profitability | 0% | 53% | 71% | 92% |
| Total debt ratio | 90.22% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 18% | 14% | 25% |
| Current Ratio | 4.71% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 4.56% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 0.44% | 0.31% | 0.62% | 0.55% |
| Liquididy | 68% | 25% | 44% | 38% |